Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations

S Quesada, M Fabbro, J Solassol - Cancers, 2022 - mdpi.com
Simple Summary High-grade serous ovarian cancer (HGSOC) is the most frequent and
lethal form of ovarian cancer and is associated with homologous recombination deficiency …

Proteomic signature for detection of high‐grade ovarian cancer in germline BRCA mutation carriers

K Bahar‐Shany, GD Barnabas… - … journal of cancer, 2023 - Wiley Online Library
No current screening methods for high‐grade ovarian cancer (HGOC) guarantee effective
early detection for high‐risk women such as germline BRCA mutation carriers. Therefore …

Phase II trial of chemopreventive effects of levonorgestrel on ovarian and fallopian tube epithelium in women at high risk for ovarian cancer: an NRG oncology group …

GC Rodriguez, J Kauderer, J Hunn, LG Thaete… - Cancer Prevention …, 2019 - AACR
A large body of epidemiologic evidence has shown that use of progestin-containing
preparations lowers ovarian cancer risk. The purpose of the current study was to gather …

[HTML][HTML] Bilateral ovarian carcinomas differ in the expression of metastasis-related genes

ML Smebye, L Haugom, B Davidson… - Oncology …, 2017 - spandidos-publications.com
The mechanisms behind bilaterality of ovarian carcinomas are not fully understood, as the
two tumors could possibly represent two primary tumors, a primary tumor and a metastasis …